Urology · Tucson, AZ
NPI
1538161880
Since 2005
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2260 W Orange Grove Rd
Tucson, AZ, 85741
Phone (520) 795-5830
Groups this clinician bills Medicare through
Medicare paid, 2024
$236K
15,810 services
Medicare patients, 2024
470
Average age 78
Drug cost, 2024
$1.7M
1,336 prescriptions
Company payments, 2025
$22K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Curtis J Dunshee was code J0897 (injection, denosumab, 1 mg), 3,360 times for 18 patients. In total Curtis J Dunshee billed 15,810 services in 74 codes, and Medicare paid $236K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,360 | 18 | $20.68 | $69K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 465 | 293 | $11.61 | $5,397 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 312 | 47 | $46.91 | $15K |
| 99214 Office E&M - Established | Office | 296 | 183 | $91.61 | $27K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 249 | 29 | $131.10 | $33K |
| 99213 Office E&M - Established | Office | 214 | 173 | $60.12 | $13K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 204 | 29 | $44.72 | $9,123 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 102 | 34 | $36.02 | $3,674 |
| 81001 Clinical Chemistry | Office | 93 | 78 | $3.11 | $289 |
| 52000 Cystourethroscopy | Facility | 77 | 65 | $60.04 | $4,623 |
| 96372 Injection Administration | Office | 75 | 37 | $9.98 | $748 |
| 64566 Musculoskeletal | Office | 69 | 28 | $86.82 | $5,990 |
| 36415 Venipuncture Blood Collection | Office | 63 | 53 | $8.51 | $536 |
| 51798 Ultrasound - Nonspecific | Office | 63 | 53 | $8.14 | $513 |
| 96402 Chemotherapy Administration | Office | 53 | 29 | $23.55 | $1,248 |
By year: 2022 $292K for 15,989 services; 2023 $280K for 11,926 services; 2024 $236K for 15,810 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81001 Clinical Chemistry | 93 | 78 | $3.11 | $289 |
| 36415 Venipuncture Blood Collection | 63 | 53 | $8.51 | $536 |
| 84153 Clinical Chemistry | 28 | 21 | $18.02 | $505 |
| 81003 Clinical Chemistry | 12 | 12 | $2.20 | $26.4 |
Medicare prescription drug claims, 2024
In 2024, the drug Curtis J Dunshee prescribed most often to Medicare patients was Tamsulosin Hcl, with 286 prescriptions and refills. In total Curtis J Dunshee wrote 1,336 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 286 | 811 | 94 | $4,183 |
| Finasteride Generic | 205 | 608 | 69 | $2,489 |
| Abiraterone Acetate Generic | 130 | 135 | 24 | $241K |
| Prednisone Generic | 93 | 187 | 26 | $639 |
| Orgovyx Relugolix | 79 | 79 | 18 | $206K |
| Xtandi Enzalutamide | 43 | 45 | Under 11 | $604K |
| Myrbetriq Mirabegron | 41 | 71 | Under 11 | $31K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 37 | 69 | 14 | $742 |
| Potassium Citrate Er Potassium Citrate | 32 | 89 | 12 | $4,780 |
| Testosterone Generic | 32 | 61 | Under 11 | $6,168 |
| Testosterone Cypionate Generic | 31 | 89 | 12 | $1,287 |
| Ciprofloxacin Hcl Generic | 29 | 29 | 21 | $207 |
| Nubeqa Darolutamide | 23 | 23 | Under 11 | $308K |
| Terazosin Hcl Generic | 19 | 57 | Under 11 | $546 |
| Tadalafil Generic | 16 | 33 | Under 11 | $404 |
Brand drugs: 241 claims; generic drugs: 1,095 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Curtis J Dunshee $22K ($718 in general payments such as food, travel and fees and $22K for research) from 15 companies. The largest payer was Pfizer Inc. with $12K.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 15 | $12K |
| Dendreon Pharmaceuticals LLC | 4 | $9,838 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $142 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $128 |
| Calyxo, Inc. | 2 | $106 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $78.76 |
| Janssen Biotech, Inc. JNJ | 2 | $55.29 |
| Novo Nordisk Inc NVO | 1 | $28.42 |
| Urogen Pharma, Inc. URGN | 1 | $24.02 |
| Baxter Healthcare BAX | 1 | $17.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.